# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-23-039836
Filing Date
2023-11-08
Accepted
2023-11-08 08:45:12
Documents
14
Period of Report
2023-11-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 38308
2 |  | ex99-1.htm | EX-99.1 | 1981
3 |  | ex99-1_001.jpg | GRAPHIC | 1151077
| Complete submission text file | 0001493152-23-039836.txt |  | 1797435

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | aim-20231108.xsd | EX-101.SCH | 3015
5 | XBRL LABEL FILE | aim-20231108_lab.xml | EX-101.LAB | 34240
6 | XBRL PRESENTATION FILE | aim-20231108_pre.xml | EX-101.PRE | 22360
8 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3214

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 231386167
SIC: 2836 Biological Products, (No Diagnostic Substances)